Connect your AI

Mesa Laboratories MLAB Stock-Based Comp

Stock-Based Comp at other companies

3MMMM

$80M-5.9%

Thermo Fisher ScientificTMO

$83M+10.7%

DanaherDHR

$58M-4.9%

STERISSTE

$12.9M+31.6%

Charles River LaboratoriesCRL

$22.38M+70.4%

FortiveFTV

$21.3M-9.0%

Other financials

Income statement

Revenue$63.7M+2.6%

Gross profit$31.2M-0.5%

Operating income-$664.0K+85.5%

Net income$3.6M+317%

EPS (diluted)-$0.10+63.0%

Balance sheet

Cash & equivalents$26.9M-1.4%

Total debt$78.7M-53.1%

Total equity$186.2M+16.5%

Total assets$427.7M-1.3%

Cash flow

Operating cash flow$14.0M+10.2%

CapEx$417.0K-44.9%

Free cash flow$13.5M+13.7%

Valuation

Market cap$542.27M+3.7%

Enterprise value$594.05M-10.4%

P/S2.2×0.0×

Profitability

Gross margin56.8%—

Operating margin2.3%—

Net margin1.5%+0.8pp

FCF margin15.9%-1.8pp

Returns & leverage

Return on equity2.2%+1.1pp

Debt / equity0.4×-0.6×

Current ratio1.7×+1.1×

Where this comes from

Reported directly by Mesa Laboratories in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Mesa Laboratories’s 10-K, filed June 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mesa Laboratories's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Mesa Laboratories's stock-based comp?: Mesa Laboratories (MLAB) reported stock-based comp of $6.79M in Q1 2026.
How has Mesa Laboratories's stock-based comp changed year-over-year?: Mesa Laboratories's stock-based comp increased by 116.5% year-over-year, from $3.14M to $6.79M.
What is the long-term trend for Mesa Laboratories's stock-based comp?: Over 4 years (2022 to 2026), Mesa Laboratories's stock-based comp has grown at a 11.9% compound annual growth rate (CAGR), from $11.39M to $17.87M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.